Sarepta Therapeutics

EXONDYS-51

Manufacturer:

Sarepta Therapeutics

Exondys-51 HCPCS:

J1428

HCPCS Code Descriptor:

Injection, eteplirsen, 10 mg

Category:

J Code

Exondys-51 NDCs:

60923-0284-10, 60923-0363-02

Primary Type:

Genetic Disorder

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Exondys-51:

EXONDYS-51 is a Genetic Disorder drug manufactured by Sarepta Therapeutics and administered via the Intravenous route of administration. The J Code: J1428 is aligned to the drug EXONDYS-51.

ACCESS PRICING AND MORE BY REGISTERING

J1428 Added Date:

January 1, 2018

J1428 Effective Date:

January 1, 2018

J1428 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Exondys-51 billing and coding information.
Exondys-51 patient assistance information can be found through SareptAssist at the URL: https://www.exondys51.com/getting-support
EXONDYS-51 prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for EXONDYS-51. Please check back in a few weeks.